HiberGene is a diagnostics company utilising the latest medical
technology to develop, market and manufacture diagnostic tests for
human infectious diseases. Using a novel rapid amplification platform,
HiberGene has developed a rapid and highly sensitive diagnostic
test for meningitis.
HiberGene have developed a test for meningitis which is:
- Fast – less than 40 minutes
- Sensitive – 100%
- Specific – 99.7%
- Requires minimal laboratory instrumentation, allowing the test
to be used in almost any clinical or laboratory setting.
In addition to the test for Meningococcus, HiberGene is also developing
a test for Pneumococcal Meningitis.
HiberGene has negotiated license agreements with the Belfast Health
and Social Care Trust for exclusive worldwide use of patents associated
with the Meningitis test.
Using the novel rapid amplification platform, HiberGene intends
to develop a range of tests for a number of infectious human diseases
including Healthcare Associated Infections and Sexually Transmitted